We are live on
!
Find out more
Rubric Capital Management (New York) Portfolio holdings
AUM
$10.9B
Turnover
31.68%
1-Year Est. Return
70.31%
This Fund
S&P 500
This Quarter
Est. Return
+19.17%
1 Year Est. Return
+70.31%
3 Year Est. Return
+250.68%
5 Year Est. Return
+304.91%
10 Year Est. Return
–
AUM
$10.9B
AUM Growth
+$1.46B
(+15%)
Cap. Flow
+$1.48B
Cap. Flow
% of AUM
13.59%
Top 10 Holdings %
Top 10 Hldgs %
46.43%
Holding
101
New
18
Increased
33
Reduced
12
Closed
14
Avg Time Held Equity + Options
1.6
years
Top 10 Avg Time Held Equity + Options
1.4
years
Top 20 Avg Time Held Equity + Options
1.3
years
Avg Time Held Equity only
1.6
years
Top 10 Avg Time Held Equity only
1.4
years
Top 20 Avg Time Held Equity only
1.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fluor
FLR
|
+$246M |
| 2 |
Amazon
AMZN
|
+$226M |
| 3 |
Gildan
GIL
|
+$178M |
| 4 |
Zoom
ZM
|
+$167M |
| 5 |
PennyMac Financial
PFSI
|
+$143M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Constellation Energy
CEG
|
+$200M |
| 2 |
Akamai
AKAM
|
+$149M |
| 3 |
Telephone and Data Systems
TDS
|
+$77.9M |
| 4 |
Adeia
ADEA
|
+$63.7M |
| 5 |
Mercury Insurance
MCY
|
+$60.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.1% |
| 2 | Utilities | 18.51% |
| 3 | Industrials | 14.51% |
| 4 | Consumer Discretionary | 7.69% |
| 5 | Energy | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
Protolabs
PRLB
$2.05B
| $8.86M | 0.08% |
108,692
-377,708
| -78% | -$26.6M |
2025 Q1
5 quarters
|
|
77
Grupo Aeromexico SAB de CV
AERO
$2.33B
| $8.41M | 0.08% |
467,129
| – | – |
2026 Q1
1 quarter
|
|
78
Omeros
OMER
$1.17B
| $6.25M | 0.06% |
+656,874
| New | +$7.82M |
2026 Q2
0 quarters
|
|
79
Eupraxia Pharmaceuticals
EPRX
$437M
| $5.73M | 0.05% |
867,424
+176,254
| +26% | +$1.22M |
2026 Q1
1 quarter
|
|
80
Edesa Biotech
EDSA
$24.8M
| $5.44M | 0.05% |
669,500
-18,000
| -3% | -$162K |
2025 Q1
5 quarters
|
|
81
Mereo BioPharma
MREO
$48.4M
| $4.86M | 0.04% |
15,307,347
| – | – |
2020 Q4
22 quarters
|
|
82
Abeona Therapeutics
ABEO
$253M
| $3.76M | 0.03% |
+608,771
| New | +$3.34M |
2026 Q2
0 quarters
|
|
83
Carter's
CRI
$1.15B
| $3.57M | 0.03% |
86,844
-932,009
| -91% | -$35.3M |
2025 Q4
2 quarters
|
|
84
TherapeuticsMD
TXMD
$22M
| $2.63M | 0.02% |
1,192,191
| – | – |
2018 Q4
30 quarters
|
|
85
TETRA Technologies
TTI
$788M
| $1.7M | 0.02% |
+150,000
| New | +$1.47M |
2026 Q2
0 quarters
|
|
|
SVC
86
Service Properties Trust
SVC
$796M
| $1.52M | 0.01% |
+180,000
| New | +$1.42M |
2026 Q2
0 quarters
|
|
87
Acadia Healthcare
ACHC
$2.79B
| – | – |
-850,000
| Closed | -$19.9M | – |
|
|
88
Akamai
AKAM
$12.6B
| – | – |
-1,300,000
| Closed | -$149M | – |
|
89
BioMarin Pharmaceuticals
BMRN
$10.6B
| – | – |
-440,560
| Closed | -$24.9M | – |
|
|
90
Constellation Energy
CEG
$96.1B
| – | – |
-715,000
| Closed | -$200M | – |
|
91
Capri Holdings
CPRI
$1.81B
| – | – |
-675,000
| Closed | -$11.9M | – |
|
92
DELISTED
Calavo Growers
CVGW
| – | – |
-1,416,662
| Closed | -$36.5M | – |
|
93
Embecta
EMBC
$355M
| – | – |
-1,037,416
| Closed | -$9.17M | – |
|
94
Helen of Troy
HELE
$678M
| – | – |
-366,226
| Closed | -$5.28M | – |
|
95
Indivior Pharmaceuticals
INDV
$3.83B
| – | – |
-662,515
| Closed | -$20.2M | – |
|
96
PUT
iShares Russell 2000 ETF
IWM
$76.2B
| – | – |
-5,150,000
| Closed | -$1.28B | – |
|
97
PLAYSTUDIOS Inc
MYPS
$47.6M
| – | – |
-269,738
| Closed | -$1.27M | – |
|
98
Protagonist Therapeutics
PTGX
$8.33B
| – | – |
-427,998
| Closed | -$45.1M | – |
|
|
99
Telephone and Data Systems
TDS
$3.9B
| – | – |
-1,850,000
| Closed | -$77.9M | – |
|
100
Telesat
TSAT
$684M
| – | – |
-843,781
| Closed | -$30.5M | – |
|
Similar funds
Rubric Capital Management (New York)'s Q2 2026 Portfolio in Review
As of Q2 2026, Rubric Capital Management (New York) held 101 positions worth $10.9B, up 15% from $9.44B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Rubric Capital Management (New York) deployed $1.48B of net new capital in Q2 2026, opening 18 new positions and adding to 33 existing holdings. Its largest new stake was Fluor: 5,017,248 shares worth $263M.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 28% a quarter earlier, followed by Utilities and Industrials.
On the sell side, the largest reduction was Adeia, an estimated $63.7M trimmed.
- Rubric Capital Management (New York)'s largest Q2 2026 buy was Fluor: 5,017,248 shares worth $263M.
- Rubric Capital Management (New York) added most to Gildan in Q2 2026, an estimated $178M increase.
- Rubric Capital Management (New York)'s biggest Q2 2026 reduction was Adeia, cutting an estimated $63.7M.
- Rubric Capital Management (New York) fully exited Constellation Energy in Q2 2026, selling an estimated $200M.
- Rubric Capital Management (New York)'s ten largest holdings make up 46% of its $10.9B portfolio in Q2 2026.
- Rubric Capital Management (New York) opened 18 new positions and closed 14 in Q2 2026.
- Rubric Capital Management (New York)'s portfolio value rose 15% quarter-over-quarter to $10.9B.
Based on Rubric Capital Management (New York)'s 13F filing for Q2 2026, filed 14 Aug 2026.